Genetic testing stories

May 30, 2026

DNA Test Could Allow Millions of Breast Cancer Patients to Safely Avoid Chemotherapy

Scientists have developed a DNA test that can distinguish between breast cancer patients who are likely to benefit from chemotherapy and those who can safely avoid it, potentially sparing millions from unnecessary treatment.

May 30, 2026·1 source

Apr 15, 2026

BRCA Gene Mutations Now Linked to Thyroid, Bladder, Skin and Head-Neck Cancers

International research led by RIKEN Center for Integrative Medical Sciences discovered new associations between pathogenic BRCA1 and BRCA2 gene variants and four additional cancer types beyond the previously known breast and ovarian cancers.

Apr 15, 2026·1 source

Top claims

▪Chemotherapy is often recommended after breast cancer surgery to diminish the risk of the disease returning.
▪The findings of the University College London breast cancer study will be presented at the American Society of Clinical Oncology's annual meeting in Chicago on June 1, 2026.
▪The University College London breast cancer study included patients in the UK, Norway, Sweden, Australia, New Zealand and Thailand.

Subtopics

Cancer diagnosis Precision medicine Cancer treatment breakthroughs Preventive longevity physicians Biomarkers & bloodwork testing

Personalized medicine

Related timelines

Genetic testing stories

DNA Test Could Allow Millions of Breast Cancer Patients to Safely Avoid Chemotherapy

BRCA Gene Mutations Now Linked to Thyroid, Bladder, Skin and Head-Neck Cancers

Related timelines

US Congress

Venture capital funding

Iran War

Strait of Hormuz blockage

Trump administration